| Literature DB >> 25796131 |
Elise Cuyvers1, Julie van der Zee1, Karolien Bettens1, Sebastiaan Engelborghs2, Mathieu Vandenbulcke3, Caroline Robberecht1, Lubina Dillen1, Céline Merlin1, Nathalie Geerts1, Caroline Graff4, Håkan Thonberg4, Huei-Hsin Chiang5, Pau Pastor6, Sara Ortega-Cubero7, Maria A Pastor8, Janine Diehl-Schmid9, Panagiotis Alexopoulos9, Luisa Benussi10, Roberta Ghidoni10, Giuliano Binetti10, Benedetta Nacmias11, Sandro Sorbi11, Raquel Sanchez-Valle12, Albert Lladó12, Ellen Gelpi13, Maria Rosário Almeida14, Isabel Santana14, Jordi Clarimon15, Alberto Lleó15, Juan Fortea15, Alexandre de Mendonça16, Madalena Martins16, Barbara Borroni17, Alessandro Padovani17, Radoslav Matěj18, Zdenek Rohan19, Agustín Ruiz20, Giovanni B Frisoni21, Gian Maria Fabrizi22, Rik Vandenberghe23, Peter P De Deyn24, Christine Van Broeckhoven25, Kristel Sleegers26.
Abstract
Meta-analysis of existing genome-wide association studies on Alzheimer's disease (AD) showed subgenome-wide association of an intronic variant in the sequestosome 1 (SQSTM1) gene with AD. We performed targeted resequencing of SQSTM1 in Flanders-Belgian AD patients selected to be enriched for a genetic background (n = 435) and geographically matched nonaffected individuals (n = 872) to investigate the role of both common and rare SQSTM1 variants. Results were extended to the European early-onset dementia cohorts (926 early-onset Alzheimer's disease [EOAD] patients and 1476 nonaffected individuals). Of the 61 detected exonic variants in SQSTM1, the majority were rare (n = 57). Rare variant (minor allele frequency <0.01) burden analysis did not reveal an increased frequency of rare variants in EOAD patients in any of the separate study populations nor when meta-analyzing all cohorts. Common variants p.D292= and p.R312= showed nominal association with AD (odds ratiop.D292= = 1.11 [95% confidence interval = 1-1.22], p = 0.04), only when including the Flanders-Belgian cohort in the meta-analysis. We cannot exclude a role of SQSTM1 genetic variability in late-onset AD, but our data indicate that SQSTM1 does not play a major role in the etiology of EOAD.Entities:
Keywords: Alzheimer's disease; European early-onset dementia consortium; Meta-analysis; Rare variants; SQSTM1/p62
Mesh:
Substances:
Year: 2015 PMID: 25796131 DOI: 10.1016/j.neurobiolaging.2015.02.014
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673